Nobel Prize in Chemistry 2026 to Henri B. Kagan and Kenso Soai

You can now design drugs with higher precision because chemists understand how to make only the desired mirror image of a molecule.

The Royal Swedish Academy of Sciences has awarded the 2026 Nobel Prize in Chemistry to Henri B. Kagan of Université Paris-Sud, France, and Kenso Soai of Tokyo University of Science, Japan. They are recognized for their groundbreaking discoveries in asymmetric organic synthesis, specifically for unraveling the mystery of how homochirality emerges in chemical reactions. Kagan's initial work in 1986 demonstrated a novel method to create an excess of one molecular mirror image, while Soai, through key publications in 1995 and subsequent success in 2003, developed the first chemical reaction capable of producing a single enantiomer. These advancements are crucial for chemists, particularly in the pharmaceutical industry, where the specific mirror image of a molecule determines its biological effect.

The Nobel laureates' work addresses the fundamental challenge of chirality, a concept central to the functioning of life and the development of pharmaceuticals. For decades, chemists struggled to control the production of specific enantiomers, leading to racemic mixtures where both mirror images are present in equal amounts. Kagan and Soai's discoveries provide a crucial pathway to achieving enantioselective synthesis, enabling the creation of molecules with a single, desired spatial orientation.

This breakthrough has significant implications for drug discovery and manufacturing, potentially leading to more effective and safer medicines by ensuring only the therapeutically active enantiomer is produced. The ability to control homochirality also opens doors for advancements in materials science and other fields that rely on precisely structured molecules.